SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-22-006686
Filing Date
2022-02-11
Accepted
2022-02-11 07:17:38
Documents
1
Group Members
DANIEL B. ASHERMITCHELL P. KOPIN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G ea155269-13ga2intra_mymdpha.htm SC 13G/A 47155
  Complete submission text file 0001213900-22-006686.txt   48907
Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Subject) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88005 | Film No.: 22616691
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 245 PALM TRAIL DELRAY BEACH FL 33483
Business Address 245 PALM TRAIL DELRAY BEACH FL 33483 8475629030
INTRACOASTAL CAPITAL, LLC (Filed by) CIK: 0001646799 (see all company filings)

IRS No.: 320460881 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A